DVx Inc. (TYO:3079)

Market Cap	10.24B +10.1%
Revenue (ttm)	55.99B +11.3%
Net Income	225.00M -45.1%
EPS	21.45 -45.3%
Shares Out	10.50M
PE Ratio	45.45
Forward PE	n/a
Dividend	50.00 (5.12%)
Ex-Dividend Date	Mar 30, 2026

Volume	3,800
Open	976.00
Previous Close	976.00
Day's Range	975.00 - 988.00
52-Week Range	898.00 - 1,820.00
Beta	0.30
Analysts	n/a
Price Target	n/a
Earnings Date	May 15, 2026

About DVx Inc.

DVx Inc. engages in the research and development, design, purchasing/selling, import/export, repair, maintenance and inspection, and rental of medical devices and related peripheral devices in Japan. The company offers arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters; ischemia-related products, that includes RAQUOS and resolution/resolution SD; and EPS Trainer, an intracardiac electrograms simulator; and wonder belt products. The company also engages in...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 334
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 3079

Financial Performance

In fiscal year 2026, DVx Inc.'s revenue was 55.99 billion, an increase of 11.26% compared to the previous year's 50.32 billion. Earnings were 225.00 million, a decrease of -45.12%.